| Financial Year |
March 31 2023 |
| Monetary Funds |
135,339,215.10 |
| Held-for-trading Financial Assets |
241,807.42 |
| Notes Receivable |
19,998,332.07 |
| Accounts Receivable |
357,544,486.96 |
| Advances to Suppliers |
11,713,751.28 |
| Other Receivables |
4,122,875.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
294,119,837.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,876,653.34 |
| Total Current Assets |
884,919,644.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
794,889,760.15 |
| Under-construction Projects |
53,155,826.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,863,786.02 |
| R&D expenses |
-- |
| Goodwill |
31,729,797.04 |
| Long-Term Deferred and Prepaid Expenses |
2,825,900.41 |
| Deferred Income Tax Assets |
7,036,084.69 |
| Other Non-Current Assets |
7,941,516.24 |
| Sub-Total of Non-Current Assets |
1,016,327,162.36 |
| Total Assets |
1,901,246,806.40 |
| Short-Term Loans |
221,991,312.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
67,395,814.46 |
| Accounts Payable |
200,952,429.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,084,791.76 |
| Taxes Payable |
10,108,844.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,090,650.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,821,685.90 |
| Other Current Liabilities |
512,499.17 |
| Sub-Total of Current Liabilities |
568,911,880.03 |
| Long-term Loans |
229,422,817.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
429,911.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
255,953,564.73 |
| Total Liabilities |
824,865,444.76 |
| Paid-In Capital(Or Share Stock) |
211,074,680.00 |
| Capital Surplus |
547,844,069.06 |
| Surplus Reserve |
30,858,747.07 |
| LESS:Treasury Stock |
3,629,971.00 |
| Undistributed Profits |
207,253,131.29 |
| Minority Stockholder's Interest |
82,980,705.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
993,400,656.42 |
| Owner's Equity（Stockholder's Equity） |
1,076,381,361.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,901,246,806.40 |
